Clinical Trials Logo

Cardiovascular Diseases clinical trials

View clinical trials related to Cardiovascular Diseases.

Filter by:

NCT ID: NCT00046592 Completed - Clinical trials for Cardiovascular Diseases

Mechanisms of Disability in Peripheral Arterial Disease

Start date: August 2002
Phase: N/A
Study type: Observational

To determine the mechanisms by which atherosclerotic peripheral artery disease (PAD) causes functional impairment and to define the degree to which peripheral artery disease associated pathophysiologic findings change over time.

NCT ID: NCT00046579 Completed - Obesity Clinical Trials

Psychosocial Determinants of Nutrient Intake in Girls

Start date: August 2002
Phase: N/A
Study type: Observational

To better understand the determinants of nutrient intake in black and white adolescent girls and to examine the effects of nutrient intake and eating behaviors on obesity, a significant risk factor for CVD.

NCT ID: NCT00046566 Completed - Hypertension Clinical Trials

Protein Supplements to Treat High Blood Pressure

Start date: July 2002
Phase: Phase 3
Study type: Interventional

The purpose of this study is to examine the effect of dietary protein supplements on high blood pressure (BP).

NCT ID: NCT00046306 Completed - Cancer Clinical Trials

Nevada Environmental Tobacco Smoke and Health Study

Start date: n/a
Phase: Phase 3
Study type: Interventional

Workplace exposure to secondhand cigarette smoke or environmental tobacco smoke (ETS)is widespread, effecting between 19 and 49% of the U.S. workforce. The first part of this study is designed to test whether exposure to ETS in the workplace effects a person's risk of developing chronic diseases such as cardiovascular disease and cancer. The second part of this study is designed to test whether antioxidant supplementation in this group of ETS exposed individuals can reduce their risk of developing chronic disease. The study will look at 375 non-smokers who either work on a casino floor or as bartenders or cocktail servers. Initial baseline data will be collected (questionnaires and blood samples taken) and the subjects will be randomized into one of three groups, placebo, low antioxidant supplementation and high antioxidant supplementation. They will be followed over a two-year period, coming in for follow-up testing every six months. Statistical analysis will be conducted to see whether this group of ETS exposed individuals has a greater risk of developing chronic disease and whether the use of antioxidant supplements can moderate any risks.

NCT ID: NCT00041457 Completed - Clinical trials for Cardiovascular Diseases

Epidemiology of Venous Thromboembolism

Start date: July 2002
Phase: N/A
Study type: Observational

To evaluate potentially modifiable lifestyle predictors of venous thromboembolism and their joint associations with biochemical and genetic determinants.

NCT ID: NCT00041444 Completed - Hypertension Clinical Trials

Multi-Ethnic Study of Atherosclerosis (MESA) - Ancillary Eye Study

MESA-Eye
Start date: June 2002
Phase: N/A
Study type: Observational

To evaluate the relation of retinal microvascular characteristics to subclinical cardiovascular disease, clinical disease, and their risk factors in the Multi-Ethnic Study of Atherosclerosis (MESA) cohort.

NCT ID: NCT00041431 Completed - Clinical trials for Cardiovascular Diseases

Estrogen, Cytokines and Heart Failure in Women

Start date: December 2001
Phase: N/A
Study type: Interventional

To determine the effects of estrogen therapy on postmenopausal women with congestive heart failure.

NCT ID: NCT00041418 Completed - Clinical trials for Cardiovascular Diseases

Cardiac MR of Subclinical CVD: Impact of Age

Start date: September 2001
Phase: N/A
Study type: Observational

To use magnetic resonance imaging to identify subclinical atherosclerosis and left ventricular hypertrophy in the Framingham Heart Study cohort.

NCT ID: NCT00041405 Completed - Clinical trials for Cardiovascular Diseases

Mechanisms of Pro-Thrombosis in Diabetes Mellitus -- Ancillary to BARI 2D

Start date: July 2001
Phase: N/A
Study type: Observational

To determine the effect of the method of hyperglycemic management on pro- thrombotic potential in diabetic subjects.

NCT ID: NCT00041392 Completed - Clinical trials for Cardiovascular Diseases

Effects of Magnesium on Individuals Undergoing Coronary Artery Bypass Graft Surgery

POINT
Start date: December 2001
Phase: Phase 2
Study type: Interventional

The purpose of this study is to examine the effects of supplemental magnesium on the neurocognitive function of individuals undergoing coronary artery bypass graft (CABG) surgery.